Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a VEGF antagonist to treat angiogenic eye disorders

Use of a VEGF antagonist to treat angiogenic eye disorders

US Patent 10973879 · Granted Apr 13, 2021

Estimated economic value: $141,155,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative2025
Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative2025
Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative2025
Methods and formulations for treating vascular eye diseases using aflibercept an2021
Methods and formulations for treating vascular eye diseases using aflibercept an2021
Compositions comprising IL6R antibodies for the treatment of uveitis and macular2021
Compositions comprising IL6R antibodies for the treatment of uveitis and macular2021
Systems and methods for managing insurance account documents2014
Therapeutic regimen for treating cancer comprising the administration of adenovi2007
Method for preventing metalorganic precursor penetration into porous dielectrics2007
Method to improve barrier layer adhesion2004